曼卡龍(300945.SZ):控股股東擬減持不超過3%股份
格隆匯8月12日丨曼卡龍(300945.SZ)公佈,控股股東浙江萬隆曼卡龍投資有限公司(簡稱“萬隆曼卡龍”)計劃在本公告披露之日起十五個交易日後的三個月內(即2025年9月3日至2025年12月2日)以集中競價方式和大宗交易方式減持本公司股份合計不超過7,862,148股,其中任意連續90日內以集中競價方式減持不超過2,620,716股(佔本公司總股本比例1%),任意連續90日內通過大宗交易方式減持不超過5,241,432股(佔本公司總股本比例2%),即合計不超過公司總股本的3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.